Pharmaceutical composition

Details for Australian Patent Application No. 2005218759 (hide)

Owner Antisense Pharma GmbH

Inventors Egger, Tamara; Stauder, Gerhard; Schlingensiepen, Reimar; Jachimczak, Piotr; Schlingensiepen, Karl-Hermann; Bischof, Astrid; Hafner, Michael

Agent Pizzeys

Pub. Number AU-B-2005218759

PCT Pub. Number WO2005/084712

Priority 04004478.6 27.02.04 EP; 60/558,135 01.04.04 US

Filing date 28 February 2005

Wipo publication date 15 September 2005

Acceptance publication date 16 July 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 35/04 (2006.01) Antineoplastic agents

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/084712 Priority application(s): WO2005/084712

16 July 2009 Application Accepted

  Published as AU-B-2005218759

12 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005218764-Air seeder disc scraper

2005218750-Stable pharmaceutical solution formulations for pressurized metered dose inhalers